← 產業報告目錄

Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity (Hydrophobic Interaction, Mixed Mode)), Application (Pharmaceutical & Biotechnology), and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Chemicals & Materials出版日期 2025-08-01頁數 291報告編號 CH2185

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global chromatography resin market size is projected to reach USD 4.94 billion by 2030 from USD 3.02 billion in 2024, at a CAGR of 8.6% between 2025 to 2030. Chromatography resins are utilized in sensitive processes like cleaning drugs, food additives, environmental, and industrial chemicals. They are used to give separation and isolation of valuable components of a complex mixture to guarantee product purity, safety, and compliance. These resins enhance the efficiency of the separation processes, as well as reduce the processing time, and minimize the use of harsh chemicals involved in the separation processes. Chromatography resins are designed in such a way that they can be reused, exerted to different pressures and certain pH levels, and still remain effective. Besides, more industries are turning to use these resins as interest and demand in safer and high-quality biologics increases, and the enforcement of purity and contaminants involved with pharmaceuticals, food, and environmental testing. Advances in resin chemistry and functional ligands are increasing the selectivity and stability of resins, and this is increasing market penetration. With the growing separation and purification requirements being experienced in different fields, chromatography resins are of much importance in the attainment of high-performance results. Chromatography resins are now being demanded more because of the fast industrialization and increasing food processing and online retail activities across the globe. “Natural polymers type segment is projected to register the second-highest CAGR of chromatography resins market, in terms of value, during the forecast period.” During the forecast period, natural polymers are estimated to have the highest CAGR in terms of value, in the chromatography resin market due to their biocompatibility, high porosity, and the prevalence of their use in bioseparation processes. Agarose, cellulose, and dextran are ideal materials used in purification of delicate biomolecules such as proteins, enzymes, and antibodies, particularly in the biopharmaceutical industry. These polymers present a high hydrophilicity and low nonspecific binding, producing separation with greater purity and yield. With the increasing need to have monoclonal antibodies, gene therapies, and other biologics, there is a massive increase in the application of natural polymer-based resins. Moreover, they have a renewable nature and eco-friendly reputation, which could also help increase the rate of industry interest in being more sustainable and implementing green approaches to manufacturing. Continued technology development in the areas of natural polymer modification and crosslinking are also increasing their mechanical strength and applicability, and further opening them up to wider industry applicability, and further increasing their market expansion. “Pharmaceutical & biotechnology segment is projected to register the highest CAGR in the chromatography market, in terms of value, in 2030.” The pharmaceuticals and biotechnology application segment is estimated to register the highest CAGR in the chromatography resin market in the forecast period because of the all-inclusive increase in the demand for biologics, monoclonal antibodies, vaccines, and gene therapies. Chromatographic resins play an important role in the purification of those complex biomolecules in downstream processing, where purity and product integrity are paramount when it comes to chromatography resins. The booming number of cases of chronic illnesses, the growing cost of healthcare services, and the increase in personalized medicine have expedited the use of advanced drug development and production processes, of which chromatography plays a pivotal role. The increase in the pipeline of biosimilars and the quality and consistency in drug manufacturing emphasized by regulatory authorities are also driving the demand. Due to the rise in R&D and development activities worldwide by biotechnology firms and pharmaceutical companies, more biomanufacturing capacities are being established in various parts of the world, especially in emerging markets. These factors, along with ongoing innovation in resin chemistry and purification technologies, are likely to support strong growth in this application sector. “Europe is projected to register the third-highest CAGR during the forecast period in the chromatography resin market, in terms of value.” Europe is expected to record the third-highest CAGR in the chromatography resin market during the forecast period, due to its mature but continuously developing pharmaceutical and biotechnology industry. Some of the worldwide biopharma corporations, contract research organizations (CROs), and research universities extensively apply chromatography procedures to develop drugs, manage quality, and conduct clinical research. Government funding of innovation and research & development is encouraging growth in the chromatography resin market, and because of this, there is an increasing level of investment taking place in biologics and also in biosimilars. Also, on the one hand, high regulatory requirements imposed by the European Medicines Agency (EMA) promote the necessity of a high-performance purification process, and chromatography resins cannot be avoided. Despite a rather moderate rate of growth in comparison with the one observed in emerging markets in Asia Pacific, the constant improvement of life sciences, environmental and food safety testing, etc., still maintains the consistent demand. The high rates of quality, safety, and environmental friendliness make Europe a major contributor to the growth of the worldwide chromatography resin market. • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20% • By Designation: Directors - 50%, Managers - 30%, and Others - 20% • By Region: North America - 40%, Europe - 35%, Asia Pacific - 20%, Rest of World – 5% The key players profiled in the report include Bio-Rad Laboratories, Inc. (US), Merck KgaA (Germany), Danaher Corporation (US), Tosoh Corporation (Japan), Sartorius Stedim Biotech S.A. (France), Bio-Works Technologies AB (Sweden), Avantor, Inc. (US), Purolite (US), Repligen Corporation (US), Mitsubishi Chemical Group Corporation (Japan), and Thermo Fisher Scientific Inc. (US), among others. Research Coverage This report segments the market for chromatography resin based on type, technique, application, and region, and provides estimations in terms of value (USD million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies associated with the market for chromatography resin. Reasons to Buy this Report This research report is focused on various levels of analysis — industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the chromatography resin market; high-growth regions; and market drivers, restraints, and opportunities. The report provides insights on the following pointers: • Market Penetration: Comprehensive information on chromatography resin offered by top players in the global market • Analysis of key drivers (increasing pharmaceutical & biotech R&D activities, rising demand for therapeutic antibodies, mounting demand for biosimilars, rising concern for food safety, and growing use of liquid chromatography-mass spectrometry in analytics), restraints (Absence of suitable skilled professionals), opportunities (increase in contract manufacturing organizations and CROs in pharmaceutical industry, increasing demand for disposable pre-packed columns, mounting demand for chromatography in drug development and omics research, rising use of chromatography in proteomics), and challenges (accessible alternative technologies to chromatography) influencing the growth of chromatography resin market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the chromatography resin market • Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for chromatography resin across regions. • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global chromatography resin market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the chromatography resin market.
目錄 Table of Contents
1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27 1.3.2 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 31 1.5 UNITS CONSIDERED 31 1.6 STAKEHOLDERS 31 1.7 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.1.1 SECONDARY DATA 34 2.1.1.1 Key data from secondary sources 34 2.1.2 PRIMARY DATA 34 2.1.2.1 Primary interviews: Demand side and supply side 35 2.1.2.2 Key industry insights 35 2.1.2.3 Breakdown of primary interviews 36 2.2 MARKET SIZE ESTIMATION 36 2.2.1 BOTTOM-UP APPROACH 37 2.3 DATA TRIANGULATION 39 2.4 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 40 2.4.1 SUPPLY SIDE 40 2.4.2 DEMAND SIDE 41 2.5 RESEARCH ASSUMPTIONS 42 2.6 RESEARCH LIMITATIONS 42 2.7 RISK ASSESSMENT 42 3 EXECUTIVE SUMMARY 43 4 PREMIUM INSIGHTS 47 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CHROMATOGRAPHY RESINS MARKET 47 4.2 CHROMATOGRAPHY RESINS MARKET, BY REGION 47 4.3 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE AND COUNTRY 48 4.4 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE 48 4.5 REGIONAL ANALYSIS: CHROMATOGRAPHY RESINS MARKET, B TECHNIQUE 49 4.6 CHROMATOGRAPHY RESINS MARKET, BY KEY COUNTRY 49 5 MARKET OVERVIEW 50 5.1 INTRODUCTION 50 5.2 MARKET DYNAMICS 50 5.2.1 DRIVERS 51 5.2.1.1 Growing pharmaceutical and biopharmaceutical R&D activities 51 5.2.1.2 Increasing demand for therapeutic antibodies 51 5.2.1.3 Increasing demand for biosimilars 52 5.2.1.4 Rising food safety concerns 53 5.2.1.5 Increasing use of liquid chromatography-mass spectrometry in analytics and research 54 5.2.2 RESTRAINTS 55 5.2.2.1 Lack of skilled professionals 55 5.2.3 OPPORTUNITIES 56 5.2.3.1 Rise of CMOs and CROs in pharmaceutical industry 56 5.2.3.2 Growing demand for disposable pre-packed columns 56 5.2.3.3 Growing demand for chromatography in drug development and omics research 57 5.2.3.4 Growing use of chromatography in proteomics 58 5.2.4 CHALLENGES 59 5.2.4.1 Presence of alternative technologies to chromatography 59 5.3 PORTER'S FIVE FORCES ANALYSIS 59 5.3.1 THREAT OF SUBSTITUTES 60 5.3.2 BARGAINING POWER OF SUPPLIERS 61 5.3.3 BARGAINING POWER OF BUYERS 61 5.3.4 THREAT OF NEW ENTRANTS 62 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 62 5.4 KEY STAKEHOLDERS & BUYING CRITERIA 63 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 63 5.4.2 BUYING CRITERIA 64 5.5 MACROECONOMIC INDICATORS 64 5.5.1 GDP TRENDS AND FORECAST FOR MAJOR ECONOMIES 64 6 INDUSTRY TRENDS 66 6.1 SUPPLY CHAIN ANALYSIS 66 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68 6.3 ECOSYSTEM ANALYSIS 68 6.4 TRADE ANALYSIS 70 6.4.1 IMPORT SCENARIO (HS CODE 391400) 70 6.4.2 EXPORT SCENARIO (HS CODE 391400) 71 6.5 PRICING ANALYSIS 72 6.5.1 AVERAGE SELLING PRICE OF CHROMATOGRAPHY RESINS OFFERED BY KEY PLAYERS, BY TECHNIQUE, 2024 73 6.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2030 73 6.6 TECHNOLOGY ANALYSIS 74 6.6.1 KEY TECHNOLOGIES 74 6.6.1.1 Jetting 74 6.6.1.2 Microfluidics 75 6.6.2 COMPLEMENTARY TECHNOLOGIES 75 6.6.2.1 Surface modification via click chemistry 75 6.6.2.2 3D printing of chromatographic structures 76 6.7 CASE STUDY ANALYSIS 76 6.7.1 BIO-WORKS TECHNOLOGIES – WORKBEADS AFFIMAB FOR MONOCLONAL ANTIBODY PURIFICATION 76 6.7.2 CYTIVA – PROTEIN SELECT RESIN FOR TAG-BASED PROTEIN PURIFICATION 77 6.7.3 REPLIGEN – COVID-19 SPIKE PROTEIN AFFINITY RESIN FOR VACCINE DEVELOPMENT 77 6.8 REGULATORY LANDSCAPE 78 6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 6.8.2 REGULATIONS 83 6.8.2.1 REACH Regulations (EC) No. 1907/2006 – European Union (ECHA) 83 6.8.2.2 USP <665>, <661.1>, and <661.2> – United States Pharmacopeia 83 6.8.2.3 WHO GMP Guidelines for Biological Products 83 6.8.2.4 ICH Q7 – GMP for Active Pharmaceutical Ingredients 83 6.8.2.5 21 CFR Part 210 & 211 – US (FDA) 84 6.8.2.6 EudraLex Volume 4 – EU GMP Guidelines (EMA) 84 6.9 KEY CONFERENCES AND EVENTS, 2025–2026 84 6.10 INVESTMENT AND FUNDING SCENARIO 85 6.11 PATENT ANALYSIS 86 6.11.1 APPROACH 86 6.11.2 PATENT TYPES 86 6.11.3 TOP APPLICANTS 89 6.11.4 JURISDICTION ANALYSIS 90 6.12 IMPACT OF AI/GEN AI ON CHROMATOGRAPHY RESINS MARKET 91 6.13 IMPACT OF 2025 US TARIFF ON CHROMATOGRAPHY RESINS MARKET 92 6.13.1 INTRODUCTION 92 6.13.2 KEY TARIFF RATES 93 6.13.3 PRICE IMPACT ANALYSIS 93 6.13.4 IMPACT ON COUNTRY/REGION 93 6.13.4.1 US 93 6.13.4.2 Europe 94 6.13.4.3 Asia Pacific 95 6.13.5 IMPACT ON END-USE INDUSTRY 95 6.13.5.1 Food & beverage industry 95 6.13.5.2 Pharmaceutical & biotechnology industry 96 7 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE 97 7.1 INTRODUCTION 98 7.2 ION EXCHANGE CHROMATOGRAPHY 100 7.2.1 HIGH DEMAND IN BIOPHARMACEUTICAL PROCESSES TO DRIVE MARKET 100 7.2.2 CATION EXCHANGE CHROMATOGRAPHY 103 7.2.3 ANION EXCHANGE CHROMATOGRAPHY 103 7.3 AFFINITY CHROMATOGRAPHY 104 7.3.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET 104 7.3.2 BIOSPECIFIC LIGAND-BASED AFFINITY CHROMATOGRAPHY 106 7.3.2.1 Protein A affinity 106 7.3.2.2 Protein G affinity 107 7.3.2.3 Protein L affinity 107 7.3.2.4 Lectin affinity 108 7.3.2.5 Others 108 7.3.3 PSEUDO-BIOSPECIFIC LIGAND-BASED AFFINITY CHROMATOGRAPHY 108 7.3.3.1 IMAC 108 7.3.3.2 Dye-based ligands 108 7.3.3.3 Others 108 7.4 SIZE-EXCLUSION CHROMATOGRAPHY 110 7.4.1 WIDE APPLICATION IN LABORATORIES TO SUPPORT MARKET GROWTH 110 7.5 HYDROPHOBIC INTERACTION CHROMATOGRAPHY 112 7.5.1 RISING DEMAND FOR BIOSIMILARS TO DRIVE DEMAND 112 7.6 MIXED-MODE CHROMATOGRAPHY 114 7.6.1 BETTER DEGREE OF PURIFICATION THAN OTHER TECHNIQUES TO DRIVE MARKET 114 7.7 OTHER TECHNIQUES 115 7.7.1 PARTITION CHROMATOGRAPHY 116 7.7.2 ADSORPTION CHROMATOGRAPHY 116 8 CHROMATOGRAPHY RESINS MARKET, BY APPLICATION 118 8.1 INTRODUCTION 119 8.2 PHARMACEUTICAL & BIOTECHNOLOGY 120 8.2.1 INCREASED R&D EXPENDITURE OF BIOTECHNOLOGY COMPANIES TO DRIVE DEMAND 120 8.2.2 PRODUCTION 121 8.2.3 ACADEMICS & RESEARCH 122 8.3 FOOD & BEVERAGE 123 8.3.1 STRINGENT REGULATIONS FOR FOOD SAFETY TO DRIVE MARKET 123 8.4 WATER & ENVIRONMENTAL ANALYSIS 125 8.4.1 RISING DEMAND FOR SAFE WATER AND STRINGENT REGULATIONS TO DRIVE GROWTH 125 8.5 OTHER APPLICATIONS 127 9 CHROMATOGRAPHY RESINS MARKET, BY REGION 129 9.1 INTRODUCTION 130 9.2 ASIA PACIFIC 131 9.2.1 CHINA 137 9.2.1.1 Investments by companies in innovative drugs to drive market 137 9.2.2 JAPAN 139 9.2.2.1 Increasing demand for generic drugs and monoclonal antibody biosimilars to drive resin consumption 139 9.2.3 SOUTH KOREA 141 9.2.3.1 Government initiatives to boost production of biosimilars to drive market 141 9.2.4 INDIA 143 9.2.4.1 Growth of pharmaceutical & biotechnology industry to drive market 143 9.2.5 AUSTRALIA 145 9.2.5.1 Rising demand for monoclonal antibodies to drive market 145 9.2.6 NEW ZEALAND 147 9.2.6.1 Increasing demand for purification techniques in food industry to drive market 147 9.3 NORTH AMERICA 149 9.3.1 US 154 9.3.1.1 Increasing R&D investments in healthcare industry to drive demand 154 9.3.2 CANADA 156 9.3.2.1 Increased R&D activities in biopharmaceutical sector to support market growth 156 9.3.3 MEXICO 157 9.3.3.1 Initiatives to encourage biosimilars and biopharmaceutical research to drive demand 157 9.4 EUROPE 159 9.4.1 GERMANY 165 9.4.1.1 Increasing R&D investments by biotechnology companies to drive market 165 9.4.2 FRANCE 167 9.4.2.1 Increasing investments by pharmaceutical companies to drive market 167 9.4.3 UK 169 9.4.3.1 Top companies with therapeutic mAbs in different stages of R&D to drive market 169 9.4.4 ITALY 171 9.4.4.1 Established pharmaceutical industry to increase demand 171 9.4.5 SPAIN 173 9.4.5.1 Increasing R&D activities in pharmaceutical companies to drive market 173 9.4.6 SCANDINAVIA 175 9.4.6.1 Growing pharmaceutical industry to drive market 175 9.4.7 AUSTRIA 177 9.4.7.1 Increasing demand for monoclonal antibodies to drive market 177 9.4.8 SWITZERLAND 179 9.4.8.1 High investment in pharmaceutical research to have positive impact on market 179 9.5 MIDDLE EAST & AFRICA 181 9.5.1 GCC COUNTRIES 186 9.5.1.1 Saudi Arabia 187 9.5.1.1.1 Growth in pharmaceutical industry to increase demand 187 9.5.1.2 UAE 189 9.5.1.2.1 Investments in R&D facilities for production of innovative biological and generic drugs to drive demand 189 9.6 SOUTH AMERICA 190 9.6.1 BRAZIL 194 9.6.1.1 Rising demand for low-cost biosimilars to drive demand 194 10 COMPETITIVE LANDSCAPE 197 10.1 INTRODUCTION 197 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 197 10.3 MARKET SHARE ANALYSIS 198 10.4 REVENUE ANALYSIS 201 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 201 10.5.1 STARS 201 10.5.2 EMERGING LEADERS 201 10.5.3 PERVASIVE PLAYERS 202 10.5.4 PARTICIPANTS 202 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 203 10.5.5.1 Company footprint 203 10.5.5.2 Region footprint 204 10.5.5.3 Application footprint 205 10.5.5.4 Technique footprint 206 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 207 10.6.1 PROGRESSIVE COMPANIES 207 10.6.2 RESPONSIVE COMPANIES 207 10.6.3 DYNAMIC COMPANIES 207 10.6.4 STARTING BLOCKS 207 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 208 10.6.5.1 Detailed list of key startups/SMEs 208 10.6.5.2 Competitive benchmarking of key startups/SMEs 209 10.7 BRAND/PRODUCT COMPARISON ANALYSIS 209 10.8 COMPANY VALUATION AND FINANCIAL METRICS 211   10.9 COMPETITIVE SCENARIO 212 10.9.1 PRODUCT LAUNCHES 212 10.9.2 DEALS 215 10.9.3 EXPANSIONS 219 11 COMPANY PROFILES 222 11.1 MAJOR PLAYERS 222 11.1.1 BIO-RAD LABORATORIES, INC. 222 11.1.1.1 Business overview 222 11.1.1.2 Products/Solutions/Services offered 223 11.1.1.3 Recent developments 225 11.1.1.3.1 Product launches 225 11.1.1.3.2 Deals 225 11.1.1.3.3 Expansions 225 11.1.1.4 MnM view 226 11.1.1.4.1 Key strengths 226 11.1.1.4.2 Strategic choices 226 11.1.1.4.3 Weaknesses and competitive threats 226 11.1.2 MERCK KGAA 227 11.1.2.1 Business overview 227 11.1.2.2 Products/Solutions/Services offered 228 11.1.2.3 Recent developments 229 11.1.2.3.1 Product launches 229 11.1.2.3.2 Deals 229 11.1.2.3.3 Expansions 229 11.1.2.4 MnM view 230 11.1.2.4.1 Key strengths 230 11.1.2.4.2 Strategic choices 230 11.1.2.4.3 Weaknesses and competitive threats 230 11.1.3 DANAHER CORPORATION 231 11.1.3.1 Business overview 231 11.1.3.2 Products/Solutions/Services offered 232 11.1.3.3 Recent developments 233 11.1.3.3.1 Product launches 233 11.1.3.3.2 Deals 233 11.1.3.3.3 Expansions 234 11.1.3.4 MnM view 235 11.1.3.4.1 Key strengths 235 11.1.3.4.2 Strategic choices 235 11.1.3.4.3 Weaknesses and competitive threats 235   11.1.4 TOSOH CORPORATION 236 11.1.4.1 Business overview 236 11.1.4.2 Products/Solutions/Services offered 237 11.1.4.3 Recent developments 238 11.1.4.3.1 Product launches 238 11.1.4.3.2 Deals 238 11.1.4.3.3 Expansions 239 11.1.4.4 MnM view 239 11.1.4.4.1 Key strengths 239 11.1.4.4.2 Strategic choices 239 11.1.4.4.3 Weaknesses and competitive threats 240 11.1.5 SARTORIUS STEDIM BIOTECH S.A. 241 11.1.5.1 Business overview 241 11.1.5.2 Products/Solutions/Services offered 242 11.1.5.3 Recent developments 243 11.1.5.3.1 Product launches 243 11.1.5.3.2 Deals 243 11.1.5.4 MnM view 244 11.1.5.4.1 Key strengths 244 11.1.5.4.2 Strategic choices 244 11.1.5.4.3 Weaknesses and competitive threats 244 11.1.6 BIO-WORKS TECHNOLOGIES AB 245 11.1.6.1 Business overview 245 11.1.6.2 Products/Solutions/Services offered 246 11.1.6.3 Recent developments 247 11.1.6.3.1 Product launches 247 11.1.6.3.2 Deals 247 11.1.6.4 MnM view 248 11.1.6.4.1 Key strengths 248 11.1.6.4.2 Strategic choices 248 11.1.6.4.3 Weaknesses and competitive threats 248 11.1.7 AVANTOR, INC. 249 11.1.7.1 Business overview 249 11.1.7.2 Products/Solutions/Services offered 250 11.1.7.3 Recent developments 251 11.1.7.3.1 Product launches 251 11.1.7.3.2 Deals 251 11.1.7.3.3 Expansions 251 11.1.7.4 MnM view 252 11.1.7.4.1 Key strengths 252 11.1.7.4.2 Strategic choices 252 11.1.7.4.3 Weaknesses and competitive threats 252 11.1.8 MITSUBISHI CHEMICAL GROUP CORPORATION 253 11.1.8.1 Business overview 253 11.1.8.2 Products/Solutions/Services offered 254 11.1.8.3 Recent developments 254 11.1.8.3.1 Product launches 254 11.1.8.3.2 Expansions 255 11.1.9 PUROLITE 256 11.1.9.1 Business overview 256 11.1.9.2 Products/Solutions/Services offered 256 11.1.9.3 Recent developments 257 11.1.9.3.1 Product launches 257 11.1.9.3.2 Deals 257 11.1.9.3.3 Expansions 258 11.1.10 REPLIGEN CORPORATION 259 11.1.10.1 Business overview 259 11.1.10.2 Products/Solutions/Services offered 260 11.1.10.3 Recent developments 261 11.1.10.3.1 Product launches 261 11.1.10.3.2 Deals 261 11.1.10.3.3 Expansions 262 11.1.11 THERMO FISHER SCIENTIFIC INC. 263 11.1.11.1 Business overview 263 11.1.11.2 Products/Solutions/Services offered 264 11.1.11.3 Recent developments 265 11.1.11.3.1 Product launches 265 11.1.11.3.2 Deals 265 11.1.11.3.3 Expansions 266 11.2 OTHER PLAYERS 267 11.2.1 SEPRAGEN CORPORATION 267 11.2.2 STEROGENE BIOSEPARATIONS, INC. 268 11.2.3 JACOBI GROUP 269 11.2.4 CHEMRA GMBH 270 11.2.5 SUNRESIN NEW MATERIALS CO. LTD. 271 11.2.6 BIOTOOLOMICS LIMITED 272 11.2.7 CUBE BIOTECH GMBH 273 11.2.8 JSR LIFE SCIENCES, LLC 274 11.2.9 NINGBO ZHENGGUANG RESIN CO., LTD. 275 11.2.10 CONCISE SEPARATIONS 276 11.2.11 GENSCRIPT BIOTECH CORPORATION 276 11.2.12 EICHROM TECHNOLOGIES, LLC 277 11.2.13 AGILENT TECHNOLOGIES, INC. 278 11.2.14 KANEKA CORPORATION 279 12 ADJACENT & RELATED MARKETS 280 12.1 INTRODUCTION 280 12.2 LIMITATIONS 280 12.3 CHROMATOGRAPHY REAGENTS MARKET 280 12.3.1 MARKET DEFINITION 280 12.3.2 MARKET OVERVIEW 280 12.4 CHROMATOGRAPHY REAGENTS MARKET, BY REGION 281 12.4.1 NORTH AMERICA 281 12.4.2 EUROPE 282 12.4.3 ASIA PACIFIC 282 12.4.4 LATIN AMERICA 283 12.4.5 MIDDLE EAST & AFRICA 283 13 APPENDIX 284 13.1 DISCUSSION GUIDE 284 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287 13.3 CUSTOMIZATION OPTIONS 289 13.4 RELATED REPORTS 289 13.5 AUTHOR DETAILS 290
圖表清單 List of Tables & Figures
TABLE 1 CHROMATOGRAPHY RESINS MARKET: INCLUSIONS AND EXCLUSIONS OF STUDY 28 TABLE 2 CHROMATOGRAPHY RESINS MARKET: DEFINITION AND INCLUSIONS, BY TYPE 28 TABLE 3 CHROMATOGRAPHY RESINS MARKET: DEFINITION AND INCLUSIONS, BY TECHNIQUE 28 TABLE 4 CHROMATOGRAPHY RESINS MARKET: DEFINITION AND INCLUSIONS, BY APPLICATION 29 TABLE 5 CHROMATOGRAPHY RESINS MARKET: RISK ASSESSMENT 42 TABLE 6 KEY BIOLOGICS UNDER THREAT OF PATENT EXPIRY 52 TABLE 7 APPLICATIONS OF LC-MS 55 TABLE 8 ADVANTAGES OF PRE-PACKED COLUMNS 57 TABLE 9 CHROMATOGRAPHY RESINS MARKET: PORTER’S FIVE FORCES ANALYSIS 59 TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%) 63 TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 64 TABLE 12 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2021–2030 (USD BILLION) 65 TABLE 13 ROLE OF COMPANIES IN CHROMATOGRAPHY RESINS ECOSYSTEM 69 TABLE 14 IMPORT DATA RELATED TO HS CODE 391400-COMPLIANT PRODUCTS, BY REGION, 2019–2024 (USD MILLION) 71 TABLE 15 EXPORT DATA RELATED TO HS CODE 391400-COMPLIANT PRODUCTS, BY REGION, 2019–2024 (USD MILLION) 72 TABLE 16 AVERAGE SELLING PRICE TREND OF CHROMATOGRAPHY RESINS OFFERED BY KEY PLAYERS, BY TECHNIQUE, 2024 (USD/LITER) 73 TABLE 17 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 23 CHROMATOGRAPHY RESINS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 84 TABLE 24 CHROMATOGRAPHY RESINS MARKET: FUNDING/INVESTMENT SCENARIO 85 TABLE 25 CHROMATOGRAPHY RESINS MARKET: PATENT STATUS, 2014–2024 86 TABLE 26 CHROMATOGRAPHY RESINS MARKET: LIST OF MAJOR PATENTS, 2014–2024 87 TABLE 27 PATENTS BY DOW GLOBAL TECHNOLOGIES, LLC 89 TABLE 28 PATENTS BY AGC INC. 89 TABLE 29 US: ADJUSTED RECIPROCAL TARIFF RATES 93 TABLE 30 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 98 TABLE 31 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 99 TABLE 32 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 99 TABLE 33 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 99 TABLE 34 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 100 TABLE 35 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 101 TABLE 36 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 101 TABLE 37 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 101 TABLE 38 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY TYPE OF CHARGE, 2020–2024 (USD MILLION) 102 TABLE 39 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY TYPE OF CHARGE, 2025–2030 (USD MILLION) 102 TABLE 40 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY TYPE OF CHARGE, 2020–2024 (LITER) 102 TABLE 41 ION EXCHANGE: CHROMATOGRAPHY RESINS MARKET, BY TYPE OF CHARGE, 2025–2030 (LITER) 102 TABLE 42 CATION EXCHANGE CHROMATOGRAPHY RESINS: LIGAND FUNCTIONAL GROUPS 103 TABLE 43 ANION EXCHANGE CHROMATOGRAPHY RESINS: LIGAND FUNCTIONAL GROUPS 103 TABLE 44 AFFINITY CHROMATOGRAPHY RESINS: LIGANDS 104 TABLE 45 AFFINITY: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 105 TABLE 46 AFFINITY: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 105 TABLE 47 AFFINITY: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 106 TABLE 48 AFFINITY: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 106 TABLE 49 AFFINITY CHROMATOGRAPHY: LIGANDS 107 TABLE 50 AFFINITY: CHROMATOGRAPHY RESINS MARKET, BY TYPE OF LIGAND INTERACTION, 2020–2024 (USD MILLION) 109 TABLE 51 AFFINITY: CHROMATOGRAPHY RESINS MARKET, BY TYPE OF LIGAND INTERACTION, 2025–2030 (USD MILLION) 109 TABLE 52 SIZE EXCLUSION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 110 TABLE 53 SIZE EXCLUSION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 111 TABLE 54 SIZE EXCLUSION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 111 TABLE 55 SIZE EXCLUSION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 112 TABLE 56 HYDROPHOBIC INTERACTION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 112 TABLE 57 HYDROPHOBIC INTERACTION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 113 TABLE 58 HYDROPHOBIC INTERACTION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 113 TABLE 59 HYDROPHOBIC INTERACTION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 113 TABLE 60 MIXED MODE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 114 TABLE 61 MIXED MODE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 114 TABLE 62 MIXED MODE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 115 TABLE 63 MIXED MODE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 115 TABLE 64 OTHER TECHNIQUES: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 116 TABLE 65 OTHER TECHNIQUES: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 116 TABLE 66 OTHER TECHNIQUES: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 117 TABLE 67 OTHER TECHNIQUES: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 117 TABLE 68 CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 119 TABLE 69 CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 120 TABLE 70 PHARMACEUTICAL & BIOTECHNOLOGY: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 121 TABLE 71 PHARMACEUTICAL & BIOTECHNOLOGY: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 121 TABLE 72 PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 122 TABLE 73 PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTION: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 122 TABLE 74 PHARMACEUTICAL & BIOTECHNOLOGY ACADEMICS & RESEARCH: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 123 TABLE 75 PHARMACEUTICAL & BIOTECHNOLOGY ACADEMICS & RESEARCH: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 76 FOOD & BEVERAGE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 124 TABLE 77 FOOD & BEVERAGE: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 125 TABLE 78 CHEMICAL CONTAMINANTS AND CHROMATOGRAPHY TECHNOLOGIES 126 TABLE 79 WATER & ENVIRONMENTAL ANALYSIS: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 127 TABLE 80 WATER & ENVIRONMENTAL ANALYSIS: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 127 TABLE 81 OTHER APPLICATIONS: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 128 TABLE 82 OTHER APPLICATIONS: CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 128 TABLE 83 CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (USD MILLION) 130 TABLE 84 CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (USD MILLION) 130 TABLE 85 CHROMATOGRAPHY RESINS MARKET, BY REGION, 2020–2024 (LITER) 131 TABLE 86 CHROMATOGRAPHY RESINS MARKET, BY REGION, 2025–2030 (LITER) 131 TABLE 87 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 133 TABLE 88 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 133 TABLE 89 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 134 TABLE 90 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 134 TABLE 91 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 134 TABLE 92 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 135 TABLE 93 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 135 TABLE 94 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 136 TABLE 95 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (LITER) 136 TABLE 96 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (LITER) 137 TABLE 97 CHINA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 138 TABLE 98 CHINA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 138 TABLE 99 CHINA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 139 TABLE 100 CHINA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 139 TABLE 101 JAPAN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 140 TABLE 102 JAPAN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 140 TABLE 103 JAPAN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 141 TABLE 104 JAPAN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 141 TABLE 105 SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 142 TABLE 106 SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 142 TABLE 107 SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 143 TABLE 108 SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 143 TABLE 109 INDIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 144 TABLE 110 INDIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 144 TABLE 111 INDIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 145 TABLE 112 INDIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 145 TABLE 113 AUSTRALIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 146 TABLE 114 AUSTRALIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 146 TABLE 115 AUSTRALIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 147 TABLE 116 AUSTRALIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 147 TABLE 117 NEW ZEALAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 148 TABLE 118 NEW ZEALAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 148 TABLE 119 NEW ZEALAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 149 TABLE 120 NEW ZEALAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 149 TABLE 121 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 150 TABLE 122 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 151 TABLE 123 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 151 TABLE 124 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 152 TABLE 125 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 152 TABLE 126 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 152 TABLE 127 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 153 TABLE 128 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 153 TABLE 129 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (LITER) 153 TABLE 130 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (LITER) 154 TABLE 131 US: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 154 TABLE 132 US: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 155 TABLE 133 US: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 155 TABLE 134 US: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 155 TABLE 135 CANADA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 156 TABLE 136 CANADA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 156 TABLE 137 CANADA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 157 TABLE 138 CANADA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 157 TABLE 139 MEXICO: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 158 TABLE 140 MEXICO: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 158 TABLE 141 MEXICO: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 159 TABLE 142 MEXICO: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 159 TABLE 143 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 161 TABLE 144 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 161 TABLE 145 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 162 TABLE 146 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 162 TABLE 147 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 162 TABLE 148 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 163 TABLE 149 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 163 TABLE 150 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 164 TABLE 151 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (LITER) 164 TABLE 152 EUROPE: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (LITER) 165 TABLE 153 GERMANY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 166 TABLE 154 GERMANY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 166 TABLE 155 GERMANY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 167 TABLE 156 GERMANY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 167 TABLE 157 FRANCE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 168 TABLE 158 FRANCE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 168 TABLE 159 FRANCE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 169 TABLE 160 FRANCE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 169 TABLE 161 UK: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 170 TABLE 162 UK: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 170 TABLE 163 UK: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 171 TABLE 164 UK: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 171 TABLE 165 ITALY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 172 TABLE 166 ITALY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 172 TABLE 167 ITALY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 173 TABLE 168 ITALY: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 173 TABLE 169 SPAIN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 174 TABLE 170 SPAIN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 174 TABLE 171 SPAIN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 175 TABLE 172 SPAIN: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 175 TABLE 173 SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 176 TABLE 174 SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 176 TABLE 175 SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 177 TABLE 176 SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 177 TABLE 177 AUSTRIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 178 TABLE 178 AUSTRIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 178 TABLE 179 AUSTRIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 179 TABLE 180 AUSTRIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 179 TABLE 181 SWITZERLAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 180 TABLE 182 SWITZERLAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 180 TABLE 183 SWITZERLAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 181 TABLE 184 SWITZERLAND: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 181 TABLE 185 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 182 TABLE 186 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 183 TABLE 187 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 183 TABLE 188 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 184 TABLE 189 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 184 TABLE 190 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 184 TABLE 191 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 185 TABLE 192 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 185 TABLE 193 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (LITER) 186 TABLE 194 MIDDLE EAST & AFRICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (LITER) 186 TABLE 195 SAUDI ARABIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 187 TABLE 196 SAUDI ARABIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 187 TABLE 197 SAUDI ARABIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 188 TABLE 198 SAUDI ARABIA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 188 TABLE 199 UAE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 189 TABLE 200 UAE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 189 TABLE 201 UAE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 190 TABLE 202 UAE: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 190 TABLE 203 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 191 TABLE 204 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 191 TABLE 205 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 192 TABLE 206 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 192 TABLE 207 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 192 TABLE 208 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 193 TABLE 209 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 193 TABLE 210 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 193 TABLE 211 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2020–2024 (LITER) 194 TABLE 212 SOUTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY COUNTRY, 2025–2030 (LITER) 194 TABLE 213 BRAZIL: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (USD MILLION) 195 TABLE 214 BRAZIL: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (USD MILLION) 195 TABLE 215 BRAZIL: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2020–2024 (LITER) 196 TABLE 216 BRAZIL: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE, 2025–2030 (LITER) 196 TABLE 217 CHROMATOGRAPHY RESINS MARKET: KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 197 TABLE 218 CHROMATOGRAPHY RESINS MARKET: DEGREE OF COMPETITION, 2024 199 TABLE 219 CHROMATOGRAPHY RESINS MARKET: REGION FOOTPRINT 204 TABLE 220 CHROMATOGRAPHY RESINS MARKET: APPLICATION FOOTPRINT 205 TABLE 221 CHROMATOGRAPHY RESINS MARKET: TECHNIQUE FOOTPRINT 206 TABLE 222 CHROMATOGRAPHY RESINS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 208 TABLE 223 CHROMATOGRAPHY RESINS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 209 TABLE 224 CHROMATOGRAPHY RESINS MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 212 TABLE 225 CHROMATOGRAPHY RESINS MARKET: DEALS, JANUARY 2020–MAY 2025 215 TABLE 226 CHROMATOGRAPHY RESINS MARKET: EXPANSIONS, JANUARY 2020–MAY 2025 219 TABLE 227 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 222 TABLE 228 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 223 TABLE 229 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES 225 TABLE 230 BIO-RAD LABORATORIES, INC.: DEALS 225 TABLE 231 BIO-RAD LABORATORIES, INC.: EXPANSIONS 225 TABLE 232 MERCK KGAA: COMPANY OVERVIEW 227 TABLE 233 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 228 TABLE 234 MERCK KGAA: PRODUCT LAUNCHES 229 TABLE 235 MERCK KGAA: DEALS 229 TABLE 236 MERCK KGAA: EXPANSIONS 229 TABLE 237 DANAHER CORPORATION: COMPANY OVERVIEW 231 TABLE 238 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 232 TABLE 239 DANAHER CORPORATION: PRODUCT LAUNCHES 233 TABLE 240 DANAHER CORPORATION: DEALS 233 TABLE 241 DANAHER CORPORATION: EXPANSIONS 234 TABLE 242 TOSOH CORPORATION: COMPANY OVERVIEW 236 TABLE 243 TOSOH CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 237 TABLE 244 TOSOH CORPORATION: PRODUCT LAUNCHES 238 TABLE 245 TOSOH CORPORATION: DEALS 238 TABLE 246 TOSOH CORPORATION: EXPANSIONS 239 TABLE 247 SARTORIUS STEDIM BIOTECH S.A.: COMPANY OVERVIEW 241 TABLE 248 SARTORIUS STEDIM BIOTECH S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 242 TABLE 249 SARTORIUS STEDIM BIOTECH S.A.: PRODUCT LAUNCHES 243 TABLE 250 SARTORIUS STEDIM BIOTECH S.A.: DEALS 243 TABLE 251 BIO-WORKS TECHNOLOGIES AB: COMPANY OVERVIEW 245 TABLE 252 BIO-WORKS TECHNOLOGIES AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED 246 TABLE 253 BIO-WORKS TECHNOLOGIES AB: PRODUCT LAUNCHES 247 TABLE 254 BIO-WORKS TECHNOLOGIES AB: DEALS 247 TABLE 255 AVANTOR, INC.: COMPANY OVERVIEW 249 TABLE 256 AVANTOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 250 TABLE 257 AVANTOR, INC.: PRODUCT LAUNCHES 251 TABLE 258 AVANTOR, INC.: DEALS 251 TABLE 259 AVANTOR, INC.: EXPANSIONS 251 TABLE 260 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY OVERVIEW 253 TABLE 261 MITSUBISHI CHEMICAL GROUP CORPORATION: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 254 TABLE 262 MITSUBISHI CHEMICAL GROUP CORPORATION: PRODUCT LAUNCHES 254 TABLE 263 MITSUBISHI CHEMICAL GROUP CORPORATION: EXPANSIONS 255 TABLE 264 PUROLITE: COMPANY OVERVIEW 256 TABLE 265 PUROLITE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 256 TABLE 266 PUROLITE: PRODUCT LAUNCHES 257 TABLE 267 PUROLITE: DEALS 257 TABLE 268 PUROLITE: EXPANSIONS 258 TABLE 269 REPLIGEN CORPORATION: COMPANY OVERVIEW 259 TABLE 270 REPLIGEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 260 TABLE 271 REPLIGEN CORPORATION: PRODUCT LAUNCHES 261 TABLE 272 REPLIGEN CORPORATION: DEALS 261 TABLE 273 REPLIGEN CORPORATION: EXPANSIONS 262 TABLE 274 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 263 TABLE 275 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 264 TABLE 276 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 265 TABLE 277 THERMO FISHER SCIENTIFIC INC.: DEALS 265 TABLE 278 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 266 TABLE 279 SEPRAGEN CORPORATION: COMPANY OVERVIEW 267 TABLE 280 STEROGENE BIOSEPARATIONS, INC.: COMPANY OVERVIEW 268 TABLE 281 JACOBI GROUP: COMPANY OVERVIEW 269 TABLE 282 CHEMRA GMBH: COMPANY OVERVIEW 270 TABLE 283 SUNRESIN NEW MATERIALS CO. LTD.: COMPANY OVERVIEW 271 TABLE 284 BIOTOOLOMICS LIMITED: COMPANY OVERVIEW 272 TABLE 285 CUBE BIOTECH GMBH: COMPANY OVERVIEW 273 TABLE 286 JSR LIFE SCIENCES, LLC: COMPANY OVERVIEW 274 TABLE 287 NINGBO ZHENGGUANG RESIN CO., LTD.: COMPANY OVERVIEW 275 TABLE 288 CONCISE SEPARATIONS: COMPANY OVERVIEW 276 TABLE 289 GENSCRIPT BIOTECH CORPORATION: COMPANY OVERVIEW 276 TABLE 290 EICHROM TECHNOLOGIES, LLC: COMPANY OVERVIEW 277 TABLE 291 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 278 TABLE 292 KANEKA CORPORATION: COMPANY OVERVIEW 279 TABLE 293 CHROMATOGRAPHY REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 281 TABLE 294 NORTH AMERICA: CHROMATOGRAPHY REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281 TABLE 295 EUROPE: CHROMATOGRAPHY REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 282 TABLE 296 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 282 TABLE 297 LATIN AMERICA: CHROMATOGRAPHY REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 283 TABLE 298 MIDDLE EAST & AFRICA: CHROMATOGRAPHY REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 283 FIGURE 1 CHROMATOGRAPHY RESINS MARKET: SEGMENTATION AND REGIONAL SCOPE 27 FIGURE 2 CHROMATOGRAPHY RESINS MARKET: RESEARCH DESIGN 33 FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE): COMBINED REVENUE OF MAJOR PLAYERS 37 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 - BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE AND SHARE OF MAJOR PLAYERS 37 FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 2 - BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE FROM SALE OF CHROMATOGRAPHY RESINS 38 FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 - BOTTOM-UP (DEMAND SIDE): PRODUCTS SOLD AND THEIR AVERAGE SELLING PRICE 38 FIGURE 7 CHROMATOGRAPHY RESINS MARKET: DATA TRIANGULATION 39 FIGURE 8 MARKET CAGR PROJECTIONS FROM SUPPLY SIDE 40 FIGURE 9 MARKET GROWTH PROJECTIONS FROM DEMAND SIDE DRIVERS AND OPPORTUNITIES 41 FIGURE 10 PHARMACEUTICAL & BIOTECHNOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 44 FIGURE 11 NATURAL POLYMERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 44 FIGURE 12 AFFINITY CHROMATOGRAPHY TECHNIQUE TO LEAD MARKET DURING FORECAST PERIOD 45 FIGURE 13 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 46 FIGURE 14 GROWING DEMAND FROM PHARMACEUTICAL & BIOTECHNOLOGY SEGMENT TO DRIVE MARKET 47 FIGURE 15 NORTH AMERICA TO DOMINATE CHROMATOGRAPHY RESINS MARKET DURING FORECAST PERIOD 47 FIGURE 16 ION EXCHANGE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN CHROMATOGRAPHY RESINS MARKET IN 2024 48 FIGURE 17 ION EXCHANGE TO BE MOST WIDELY ADOPTED TECHNIQUE DURING FORECAST PERIOD 48 FIGURE 18 ION EXCHANGE SEGMENT LED CHROMATOGRAPHY RESINS MARKET ACROSS ALL REGIONS IN 2024 49 FIGURE 19 INDIA TO REGISTER HIGHEST CAGR BETWEEN 2025 AND 2030 49 FIGURE 20 CHROMATOGRAPHY RESINS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50 FIGURE 21 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2024 (USD BILLION) 51 FIGURE 22 WORLDWIDE GENERIC DRUG SALES, 2014–2024 (USD BILLION) 56 FIGURE 23 PORTER'S FIVE FORCES ANALYSIS: CHROMATOGRAPHY RESINS MARKET 60 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 63 FIGURE 25 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 64 FIGURE 26 CHROMATOGRAPHY RESINS MARKET: SUPPLY CHAIN ANALYSIS 66 FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68 FIGURE 28 CHROMATOGRAPHY RESINS MARKET: KEY PLAYERS IN ECOSYSTEM 69 FIGURE 29 IMPORT DATA FOR HS CODE 391400-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2024 (USD MILLION) 71 FIGURE 30 EXPORT DATA FOR HS CODE 391400-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2024 (USD MILLION) 72 FIGURE 31 AVERAGE SELLING PRICE OF CHROMATOGRAPHY RESINS OFFERED BY KEY PLAYERS, BY TECHNIQUE, 2024 73 FIGURE 32 AVERAGE SELLING PRICE TREND OF CHROMATOGRAPHY RESINS, BY REGION, 2022–2030 (USD/LITER) 74 FIGURE 33 PATENTS REGISTERED RELATED TO CHROMATOGRAPHY RESINS, 2014–2024 86 FIGURE 34 TOP PATENT OWNERS, 2014–2024 87 FIGURE 35 LEGAL STATUS OF PATENTS FILED FOR CHROMATOGRAPHY RESINS, 2014–2024 90 FIGURE 36 MAJOR PATENTS FILED IN US JURISDICTION, 2014–2024 90 FIGURE 37 CHROMATOGRAPHY RESINS MARKET: IMPACT OF AI/GEN AI 91 FIGURE 38 MIXED MODE TECHNIQUE TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 98 FIGURE 39 PHARMACEUTICAL & BIOTECHNOLOGY SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 119 FIGURE 40 ASIA PACIFIC TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 130 FIGURE 41 ASIA PACIFIC: CHROMATOGRAPHY RESINS MARKET SNAPSHOT 132 FIGURE 42 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SNAPSHOT 150 FIGURE 43 EUROPE: CHROMATOGRAPHY RESINS MARKET SNAPSHOT 160 FIGURE 44 CHROMATOGRAPHY RESINS MARKET SHARE ANALYSIS, 2024 199 FIGURE 45 CHROMATOGRAPHY RESINS MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2020–2024 (USD MILLION) 201 FIGURE 46 CHROMATOGRAPHY RESINS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 202 FIGURE 47 CHROMATOGRAPHY RESINS MARKET: COMPANY FOOTPRINT 203 FIGURE 48 CHROMATOGRAPHY RESINS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 208 FIGURE 49 CHROMATOGRAPHY RESINS MARKET: BRAND/PRODUCT COMPARISON 210 FIGURE 50 CHROMATOGRAPHY RESINS MARKET: EV/EBITDA OF KEY COMPANIES 211 FIGURE 51 CHROMATOGRAPHY RESINS MARKET: ENTERPRISE VALUATION (EV) OF KEY PLAYERS 212 FIGURE 52 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 223 FIGURE 53 MERCK KGAA: COMPANY SNAPSHOT 228 FIGURE 54 DANAHER CORPORATION: COMPANY SNAPSHOT 232 FIGURE 55 TOSOH CORPORATION: COMPANY SNAPSHOT 237 FIGURE 56 SARTORIUS STEDIM BIOTECH S.A.: COMPANY SNAPSHOT 242 FIGURE 57 BIO-WORKS TECHNOLOGIES AB: COMPANY SNAPSHOT 246 FIGURE 58 AVANTOR, INC.: COMPANY SNAPSHOT 250 FIGURE 59 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY SNAPSHOT 254 FIGURE 60 REPLIGEN CORPORATION: COMPANY SNAPSHOT 260 FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 264

同分類最新報告(化學與材料)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們